Powder cellulose in allergic rhinitis management: facts Review article

Main Article Content

Ewa Willak-Janc

Abstract

Allergic rhinitis often coexist in asthmatic patients. Cellulose powder (HPMC) due to its moisturizing and inflammatory properties, has been reported as a safe and effective complementary topical treatment of allergic rhinitis. HPMC can prevent from binding an allergen to nasal mucosa, may reduce allergic rhinitis symptoms.

Article Details

How to Cite
Willak-Janc, E. (2020). Powder cellulose in allergic rhinitis management: facts. Medycyna Faktow (J EBM), 13(1(46), 111-114. https://doi.org/10.24292/01.MF.0120.12
Section
Articles

References

1. Skoner D.P.: Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J. Allergy Clin. Immunol. 2001; 108(1): S2-8.
2. Hesselmar B., Aberg B., Eriksson B. et al.: Allergic rhinoconjunctivitis, eczema, and sensitization in two areas with differing climates. Pediatr. Allergy Immunol. 2001; 12(4): 208-215.
3. Eichel A., Bilstein A., Werkhauser N. et al.: Meta-Analysis of the efficacy of ectoine nasal spray in patient with allergic rhinoconjunctivitis. J. Allergy 2014; 2014: 292545. DOI: 10.1155/2014/292545.
4. Chen X., Guan W.J., Sun S.X. et al.: Effects of Intranasal Cellulose Powder on Asthma Control in Children With Mild-to-Moderate Perennial Allergic Rhinitis: A Randomized, Placebo-Controlled Trial. Am. J. Rhinol. Allergy 2019; 33(2): 184-193. DOI: 10.1177/1945892419826509.
5. Popov T.A., Åberg N., Emberlin J. et al.: Methyl-cellulose powder for prevention and management of nasal symptoms. Expert Rev. Respir. Med. 2017; 11(11): 885-892. DOI: 10.1080/17476348.2017.1375408.
6. Popov T.A., Emberlin J., Church M. et al.: Powder Cellulose in Allergic Rhinitis Management: Relevance of in vitro Findings to Real-Life Safety. Int. Arch. Allergy Immunol. 2019; 179(1): 1-2. DOI: 10.1159/000496514.
7. Zhou M., Zuo K.J., Xu Z. et al.: Effect of Cellulose Powder on Human Nasal Epithelial Cell Activity and Ciliary Beat Frequency. Int. Arch. Allergy Immunol. 2019; 178(3): 229-237. DOI: 10.1159/000493582.